First Trust Nasdaq Pharmaceuticals ETF
First Trust Nasdaq Pharmaceuticals ETF (FTXH) Covered Calls
First Trust Nasdaq Pharmaceuticals ETF trades in the Exchange Traded Fund industry with an IV Rank of 88.10%, high versus the past year. FTXH's highest covered call setup is the $46.00 strike expiring Jun 17, 2027, sorted by theoretical annualized return. It's 4.00% out of the money with 216 days to expiration, a 4.68% return until expiration, and a 7.91% theoretical annualized return. Across the setups shown, annualized returns run from 6.00% to 7.91% at strikes between $45.00 and $46.00, with 216 days to expiration, as of Nov 13, 2026.
Read more
Running FTXH covered calls helps you generate income from First Trust Nasdaq Pharmaceuticals ETF shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best FTXH covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If FTXH stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling FTXH covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given FTXH covered call is worth writing.
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
| 2027-06-17 | 216 | 46.00 | 4.00 | 0.30 | 5.30 | 207.00 | 4.68 | 7.91 | -0.68 | +0.50 | 0 | 5.00 |
| 2027-06-17 | 216 | 45.00 | 1.74 | 0.80 | 5.80 | 157.00 | 3.55 | 6.00 | -1.81 | +0.55 | 0 | 5.00 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryExchange Traded Fund
- SectorFinancial
- IV Rank88.10% High
- Market cap (M$)—
- 52 weeks high-7.52%
- 52 weeks low32.24%
- Analyst recommendation—
- Target price—
- Dividend—
- Payout ratio—
- Earnings date—
- P/E—
- Future P/E—
- EPS (ttm)—
- EPS growth next 5 years—
As of Nov 20, 2026